VMP 42036111000001107

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Flavoxate 200mg tablets
BNF code 0704020G0AAACAC
Virtual Therapeutic Moiety Flavoxate
Date identifier became valid 7 Jul 2023
Previous product identifier 326539000
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Flavoxate hydrochloride
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 200.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Urispas 200 tablets (Lexon (UK) Ltd)
Urispas 200 tablets (Recordati Pharmaceuticals Ltd)
Urispas 200 tablets (Sigma Pharmaceuticals Plc)
Urispas 200 tablets (Stephar (U.K.) Ltd)
Virtual Medicinal Product Packs
Flavoxate 200mg tablets 100 tablet
Flavoxate 200mg tablets 60 tablet
Flavoxate 200mg tablets 90 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.

Feedback